Considering that plasma NfL demonstrates less variability during Aβ/tau accumulation, it is plausible that plasma NfL reflects more the comorbidities in AD rather than AD itself in relation to neuronal injury and cognitive impairment. This evidence concerns the gene NEFL and Alzheimer disease.